BYAH Investor Alert: Park Ha Biological Technology Co., Ltd. Securities Class Action Notice - Contact SueWallSt

Park Ha Biological Technology Co., Ltd.'s IPO prospectus warned generically that low-float stocks "may" experience extreme run-ups, but the lawsuit contends it never disclosed that BYAH shares were already the target of a coordinated pump-and-dump promotion before the stock collapsed 93% in one session.

NEW YORK, Sept. 3, 2026 /PRNewswire/ -- SueWallSt notifies investors in Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) that a securities class action has been filed on behalf of shareholders who purchased securities between December 27, 2024 and July 8, 2025. Submit your information. You may also contact Joseph E. Levi, Esq. at [email protected] or (888) SueWallSt.

On July 8, 2025, BYAH shares fell approximately 93%, dropping $38.02 from the prior close to settle at $2.99 on volume exceeding 8.9 million shares, erasing more than $1 billion in market capitalization. The lead plaintiff deadline is September 28, 2026.

What the Company Disclosed

SEC filings stated that "[t]here have been instances of extreme stock price run-ups followed by rapid price declines and strong stock price volatility with recent initial public offerings, especially among those with relatively smaller public floats," and that BYAH shares "may be subject to rapid and substantial price volatility, low volumes of trades, and large spreads in bid and ask prices." The prospectus added that such volatility "may be unrelated to our actual or expected operating performance."

What Plaintiffs Allege Was Missing

The complaint challenges that language as hypothetical framing of a risk that had allegedly already materialized. Rather than a theoretical possibility, plaintiffs allege BYAH stock was the vehicle for an ongoing promotional scheme in which impersonators using stolen identities of real financial advisors funneled retail investors into WhatsApp groups and instructed them to buy BYAH beginning June 18, 2025, citing a fabricated L'Oréal partnership and a promised 200% to 300% price increase.

Disclosure Gaps Alleged

• Risk factors allegedly presented manipulative trading as a generic possibility rather than a known, active condition affecting BYAH shares
• No disclosure that the December 27, 2024 offering of only 1,200,000 shares left a public float under 5% of the 26,200,000 shares outstanding
• No disclosure that insiders retained more than 95% of shares, which the complaint alleges made explosive price movement possible on modest volume
• No corrective or cautionary statement as shares climbed from the $4.00 IPO price to an intraday high of $41.49 on July 7, 2025
• No press release or filing addressing the July 8, 2025 collapse, and, according to the complaint, no acknowledgment of the alleged manipulation in any later filing
• A $1 billion valuation for a business with 39 franchisees as of April 30, 2025 and $551,970 in franchise fee revenue for the six months ended April 30, 2024

Why Generic Warnings May Not Protect

The action asserts claims under Sections 11, 12 and 15 of the Securities Act and Sections 10(b) and 20(a) of the Exchange Act in the Southern District of New York.

"Generic risk factor language cannot substitute for disclosing specific, known problems that are already affecting a company's securities. Here the complaint alleges the prospectus described low-float volatility as a possibility while omitting that BYAH shares were the subject of an active promotional scheme." -- Joseph E. Levi, Esq.

Act now. Click here to learn more or call (888) SueWallSt.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the BYAH Lawsuit

Q: What specific misstatements does the BYAH lawsuit allege? A: The complaint alleges Park Ha Biological Technology Co., Ltd. made materially false or misleading statements regarding its business prospects and the risks affecting its shares, including alleged omissions about a pump-and-dump promotional scheme and an intentionally low public float. When the stock collapsed 93% on July 8, 2025 without any material corporate development to justify the prior surge, investors suffered significant losses.

Q: What court was the BYAH class action filed in? A: The case was filed in the United States District Court for the Southern District of New York, governed by the Private Securities Litigation Reform Act of 1995.

Q: Who is eligible to join the BYAH investor lawsuit? A: Investors who purchased BYAH stock or securities between December 27, 2024 and July 8, 2025 and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses, not on whether you still hold the shares.

Q: What is the BYAH lead plaintiff deadline? A: The deadline to apply for lead plaintiff appointment is September 28, 2026. This deadline applies only to investors seeking to serve as lead plaintiff. Class members who do not apply may still participate in any recovery without taking action before this date.

Q: What documents do I need to submit my information? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What happens after I contact Levi & Korsinsky? A: An attorney will review your trading history at no cost and provide an initial assessment of your potential eligibility.

Q: What if I already sold my BYAH shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought during the Class Period and sold at a loss may still be eligible to participate.

Q: What does it cost me to participate? A: There is no upfront cost to contact the firm. Securities class actions are generally handled on a pure contingency basis, with no retainer and no out-of-pocket costs. Any attorneys' fees and expenses awarded to class counsel are subject to court approval.

Q: What if I live outside the United States? A: U.S. securities class actions generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (888) SueWallSt
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

SOURCE SueWallSt.com